Zostavax
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Background On October 20, 2017, the U.S. Food and Drug Administration approved Shingrix, a new recombinant zoster vaccine (RZV…
Zostavax, a live attenuated vaccine against shingles (herpes zoster) has been available in Switzerland since 2008. In a…
In Germany, a vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia (PHN) in adults aged 50 years and older has…
Background:
Herpes zoster (HZ), or shingles, is caused by the reactivation of latent varicella-zoster virus (VZV) years after an…